Current Appointments & Affiliations
Instructor in the Department of Medicine
·
2024 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Member of the Duke Human Vaccine Institute
·
2024 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Recent Publications
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Journal Article Cell · November 13, 2025 Full text Link to item CiteA comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.
Journal Article Structure · July 3, 2025 Anti-HIV envelope broadly neutralizing antibodies (bnAbs) are alternatives to conventional antiretrovirals with the potential to prevent and treat infection, reduce latent reservoirs, and/or mediate a functional cure. Clinical trials with "first-generation ... Full text Link to item CiteTransient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.
Journal Article Cell Rep · June 24, 2025 Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 CD4-binding site (CD4bs) occur infrequently in macaques and humans and have not been reproducibly elicited in any outbred animal model. To address this challenge, we first isolated RHA10, an infec ... Full text Link to item CiteRecent Grants
Optimizing glycan shield coverage, germline B cell receptor targeting and epitope diversity of V2-apex targeted HIV-1 Env immunogens
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2024 - 2029Novel vaccine design approached to prevent HIV
ResearchPrincipal Investigator · Awarded by California Institute of Technology · 2025 - 2028SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027View All Grants
Education, Training & Certifications
Rutgers University New Brunswick ·
2013
Ph.D.